Close Menu

NEW YORK, Aug. 24 (GenomeWeb News) - The US Food and Drug Administration will use Rosetta Biosoftware's Rosetta Resolver system for genomic data management and analysis in order to analyze microarray data from sponsors, Rosetta said today.

According to Rosetta, the Center for Drug Evaluation and Research, an arm of the FDA, will use the system when evaluating genomic data submitted through the voluntary genomic data submissions program the agency initiated this year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.